BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medical Affairs Professional Society - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://medicalaffairs.org
X-WR-CALDESC:Events for Medical Affairs Professional Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251205T100000
DTEND;TZID=America/New_York:20251205T110000
DTSTAMP:20260428T002222
CREATED:20251106T225253Z
LAST-MODIFIED:20251106T225258Z
UID:57744-1764928800-1764932400@medicalaffairs.org
SUMMARY:Harnessing AI and Real-World Evidence to Advance Alzheimer’s Screening and Equitable Access
DESCRIPTION:The approval of new Alzheimer’s therapies has reshaped the landscape of diagnosis and care\, driving measurable increases in screening\, biomarker testing\, and provider engagement. Yet despite this progress\, meaningful disparities in access and treatment persist across patient populations. \n\n\n\nIn this educational webinar\, experts will present findings from a recent joint research initiative. The session will explore how AI-driven analysis of real-world data (RWD) can illuminate trends in Alzheimer’s screening\, testing\, and treatment—and critically\, where inequities remain. Given that emerging treatments create opportunities to improve patient care\, this discussion will offer a complementary perspective on how the approval of new therapies drives information-seeking among healthcare professionals (HCPs) and creates opportunities for funding and external education. \n\n\n\nUltimately\, targeted HCP education influences knowledge\, confidence\, and clinical practice—underscoring its vital role in improving equitable outcomes. \n\n\n\nAttendees will gain practical insights into: \n\n\n\n\nThe impact of new therapies on real-world screening and diagnostic practices\n\n\n\nLeveraging AI and RWE to precisely identify and quantify key disparities across race\, gender\, and insurance type\n\n\n\nHow HCP education and training can effectively close knowledge and practice gaps for more equitable care\n\n\n\nActionable approaches for Medical Affairs teams to apply these data-driven insights to their own therapeutic areas\n\n\n\n\nLearning Objectives\n\n\n\n\nAnalyze the real-world impact of new Alzheimer’s therapies on screening and diagnostic practices using AI-driven RWE.\n\n\n\nIdentify and quantify specific disparities in Alzheimer’s access and treatment across key patient demographics (race\, gender\, insurance type).\n\n\n\nEvaluate the role of targeted HCP education in addressing knowledge gaps and promoting equitable patient care.\n\n\n\nDevelop actionable strategies for applying RWE and AI approaches to illuminate inequities within their own therapeutic areas.\n\n\n\n\n\nRegister\n\n\n\n\n\n\n\n\nSpeakers:\n\n\n\n\n\n\nModerator: \n\n\n\nTabby Khan \n\n\n\nSenior Director\, Analytics \n\n\n\nKomodo Health \n\n\n\n\n\n\n\nSpeaker: \n\n\n\nKatie Lucero \n\n\n\nPhD\, Chief Impact Officer \n\n\n\nMedscape \n\n\n\n\n\n\n\nSpeaker:  \n\n\n\nRob Adamoski \n\n\n\nVice President\, Medical Affairs \n\n\n\nCorcept
URL:https://medicalaffairs.org/events/harnessing-ai-and-real-world-evidence-to-advance-alzheimers-screening-and-equitable-access/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://medicalaffairs.org/wp-content/uploads/2025/11/PC-Webinar-Banner-Komodo-120525.png
END:VEVENT
END:VCALENDAR